Clinical trial

Exploratory Study of Topical Norepinephrine in Breast Cancer Patients Receiving Radiotherapy

NCT01544504

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2012-03-01

PhasePHASE1 / PHASE2

Study timeline

Study start (unknown)2012-03-01Date precision: month

Registry last updated2012-05-28

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Radiodermatitisunresolved

Interventions

NorepinephrineDRUG · verified · RxNorm: norepinephrine

Sponsors & collaborators

ProCertus BioPharm, Inclead sponsor

H. Lee Moffitt Cancer Center and Research Institutecollaborator

Mapped research locations

TampaFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01544504 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.